Ohio State offers the newest, minimally invasive treatments for all forms of heart valve disease

The Ohio State University Heart and Vascular Center’s Structural Heart Disease Program is a leader in providing patients with heart valve disease access to the newest and most advanced treatments.

Ohio State is one of only a handful of centers in Ohio offering transcatheter aortic valve replacement (TAVR) for aortic valve regurgitation or aortic valve stenosis. We are currently participating in a variety of clinical trials, evaluating groundbreaking therapies in patients with structural heart disease.

Our dedicated program for structural heart disease offers you access to the most advanced treatments and options for every condition. We have assembled a team of experts including interventional cardiologists, cardiac surgeons, dedicated nursing staff and other specialists, to ensure you receive the most comprehensive care available.

Our team can evaluate your condition and provide treatment options for you – whether this is your initial consultation or you are looking for a second opinion. Our advanced treatment options are giving new hope to patients who previously were not considered candidates for treatment due to advanced age or condition.

Advancing Care for Structural Heart Disease at Ohio State

Transcatheter Aortic Valve Replacement

Minimally invasive treatment for severe aortic stenosis

How the TAVR Procedure Works

This video shows how the Transcatheter Aortic Valve Replacement (TAVR) procedure is performed.

Life-Saving Valve Replacement

Learn how the team at Ohio State saved Veneta's life with a transcatheter aortic valve replacement procedure.

Heart Valve Surgery: What to Expect

When a patient suffers narrowing or leakage of the heart valves, testing may reveal that the patient needs valve repair or replacement. Juan Crestanello, MD, a cardiovascular surgeon at Ohio State’s Wexner Medical Center explains the general process of heart valve surgery.

Our Leaders

Our leaders

jaun crestanello

Juan Crestanello, MD

Director, Cardiac Surgery; Co-Director, Structural Heart Disease Program

Dr. Crestanello is the section director of Ohio State's Cardiac Surgery program. He focuses on the treatment and evaluation of patients with heart valve disease and adult congenital pathologies. His research interests include minimally invasive valve surgery, valvular heart disease, hybrid coronary revascularization, and the effect of hyponatremia on cardiac surgery outcomes. 

LillyScott

Scott Lilly, MD, PhD

Scott Lilly, MD, PhD, is an interventional cardiologist and co-director of the Ohio State Structural Heart Disease program. Dr. Lilly specializes in treating aortic valve disorders. 

Share this Page